BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
August 01, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
Acoramidis demonstrated a significant impact on mortality, hospitalizations, and quality of life Starting at Month 3, patients taking acoramidis showed meaningful and sustained improvement in time to...
MGP Ingredients Reports Second Quarter 2024 Results
August 01, 2024 07:30 ET
|
MGP Ingredients
ATCHISON, Kan., Aug. 01, 2024 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, today reported results for...
Laureate Education Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024
August 01, 2024 07:30 ET
|
Laureate Education, Inc.
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the...
Altimmune to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
August 01, 2024 07:30 ET
|
Altimmune, Inc
GAITHERSBURG, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2024 financial...
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations
August 01, 2024 07:30 ET
|
Context Therapeutics Inc.
Company announces appointments of Dr. Claudio Dansky Ullmann as CMO and Ms. Karen Andreas as VP, Clinical Operations Appointments support the development of the Company’s two clinical-stage T cell...
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
August 01, 2024 07:30 ET
|
Anavex Life Sciences Corp.
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2024 Earnings and Company Updates
August 01, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
Kura Oncology to Report Second Quarter 2024 Financial Results
August 01, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
August 01, 2024 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today...
SPS Commerce Acquires SupplyPike
August 01, 2024 07:30 ET
|
SPS Commerce, Inc.
Acquisition expands company’s product portfolio with automated invoice deduction management and prevention Company to host conference call today at 8:30 a.m. ET MINNEAPOLIS, Aug. 01, 2024 ...